Array
(
[id] => 517
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/517.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:13:01
[updatetime] => 2024-01-11 15:13:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => European Society of Cardiology
[pdf] =>
[tjyjyw] =>
[lyyw] => A pre-operative assessment for concomitant cardiac conditions is recommended in patients with diabetes with suspected or known CAD, and those with autonomic neuropathy, retinopathy, or renal disease and scheduled to undergo intermediate- and high-risk NCS.(Evidence: Level C，Recommendation: Class Ⅰ)
[laiyuan] => 推荐对疑似或已知患有冠状动脉疾病的糖尿病患者，以及患有自主神经病变、视网膜病变或肾病并计划接受中高风险NCS的患者进行术前并发症评估。（证据级别：Level C ；推荐强度：Class Ⅰ）
[znzldj] => A
[_inputtime] => 1704957181
[_updatetime] => 1704957181
[_nrjc] =>
[_nrsh] =>
)
推荐意见
推荐对疑似或已知患有冠状动脉疾病的糖尿病患者，以及患有自主神经病变、视网膜病变或肾病并计划接受中高风险NCS的患者进行术前并发症评估。（证据级别：Level C ；推荐强度：Class Ⅰ）
A pre-operative assessment for concomitant cardiac conditions is recommended in patients with diabetes with suspected or known CAD, and those with autonomic neuropathy, retinopathy, or renal disease and scheduled to undergo intermediate- and high-risk NCS.(Evidence: Level C，Recommendation: Class Ⅰ)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：European Society of Cardiology
Array
(
[id] => 518
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/518.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:13:01
[updatetime] => 2024-01-11 15:13:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => European Society of Cardiology
[pdf] =>
[tjyjyw] =>
[lyyw] => Stress imaging is recommended before high-risk elective NCS in patients with poor functional capacity and high likelihood of CAD or high clinical risk. (Evidence: Level B，Recommendation: Class Ⅰ)
[laiyuan] => 对于功能储备差、冠心病可能性大或临床高风险患者，推荐在高危择期NCS前进行运动显像检查。（证据级别：Level B ；推荐强度：Class Ⅰ）
[znzldj] => A
[_inputtime] => 1704957181
[_updatetime] => 1704957181
[_nrjc] =>
[_nrsh] =>
)
推荐意见
对于功能储备差、冠心病可能性大或临床高风险患者，推荐在高危择期NCS前进行运动显像检查。（证据级别：Level B ；推荐强度：Class Ⅰ）
Stress imaging is recommended before high-risk elective NCS in patients with poor functional capacity and high likelihood of CAD or high clinical risk. (Evidence: Level B，Recommendation: Class Ⅰ)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：European Society of Cardiology
Array
(
[id] => 519
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/519.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:13:01
[updatetime] => 2024-01-11 15:13:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => European Society of Cardiology
[pdf] =>
[tjyjyw] =>
[lyyw] => In low-risk patients undergoing low- and intermediate-risk NCS, it is not recommended to routinely obtain pre-operative ECG, hs-cTn T/I, or BNP/NT-proBNP concentrations. (Evidence: Level B，Recommendation: Class Ⅲ)
[laiyuan] => 对于接受低危和中危NCS 的低危患者，不推荐常规术前心电图、高敏肌钙蛋白 T/I 或 BNP/NT-proBNP 浓度。（证据级别：Level B ；推荐强度：Class Ⅲ）
[znzldj] => A
[_inputtime] => 1704957181
[_updatetime] => 1704957181
[_nrjc] =>
[_nrsh] =>
)
推荐意见
对于接受低危和中危NCS 的低危患者，不推荐常规术前心电图、高敏肌钙蛋白 T/I 或 BNP/NT-proBNP 浓度。（证据级别：Level B ；推荐强度：Class Ⅲ）
In low-risk patients undergoing low- and intermediate-risk NCS, it is not recommended to routinely obtain pre-operative ECG, hs-cTn T/I, or BNP/NT-proBNP concentrations. (Evidence: Level B，Recommendation: Class Ⅲ)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：European Society of Cardiology
Array
(
[id] => 520
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/520.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:13:01
[updatetime] => 2024-01-11 15:13:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => European Society of Cardiology
[pdf] =>
[tjyjyw] =>
[lyyw] => TTE is recommended in patients with poor functional capacity and/or high NT-proBNP/BNP, or if murmurs are detected before high-risk NCS, in order to undertake risk-reduction strategies. (Evidence: Level B，Recommendation: Class Ⅰ)
[laiyuan] => 心功能储备差和（或） NT-proBNP/BNP 高，或有心脏杂音的患者在高风险NCS术前应检查经胸超声心动图以便采取降低风险的策略（证据级别：Level B ；推荐强度：Class Ⅰ）
[znzldj] => A
[_inputtime] => 1704957181
[_updatetime] => 1704957181
[_nrjc] =>
[_nrsh] =>
)
推荐意见
心功能储备差和（或） NT-proBNP/BNP 高，或有心脏杂音的患者在高风险NCS术前应检查经胸超声心动图以便采取降低风险的策略（证据级别：Level B ；推荐强度：Class Ⅰ）
TTE is recommended in patients with poor functional capacity and/or high NT-proBNP/BNP, or if murmurs are detected before high-risk NCS, in order to undertake risk-reduction strategies. (Evidence: Level B，Recommendation: Class Ⅰ)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：European Society of Cardiology
Array
(
[id] => 521
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/521.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:13:01
[updatetime] => 2024-01-11 15:13:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => European Society of Cardiology
[pdf] =>
[tjyjyw] =>
[lyyw] => If a patient scheduled for elective NCS has chest pain or other symptoms suggestive of undetected CAD, further diagnostic work-up before NCS is recommended. (Evidence: Level C，Recommendation: Class Ⅰ)
[laiyuan] => 如果计划进行择期NCS的患者有胸痛或其他症状而提示未检测到冠心病,则推荐在非心脏手术之前进行进一步的诊断检查。（证据级别：Level C ；推荐强度：Class Ⅰ）
[znzldj] => A
[_inputtime] => 1704957181
[_updatetime] => 1704957181
[_nrjc] =>
[_nrsh] =>
)
推荐意见
如果计划进行择期NCS的患者有胸痛或其他症状而提示未检测到冠心病,则推荐在非心脏手术之前进行进一步的诊断检查。（证据级别：Level C ；推荐强度：Class Ⅰ）
If a patient scheduled for elective NCS has chest pain or other symptoms suggestive of undetected CAD, further diagnostic work-up before NCS is recommended. (Evidence: Level C，Recommendation: Class Ⅰ)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：European Society of Cardiology
Array
(
[id] => 522
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/522.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:13:01
[updatetime] => 2024-01-11 15:13:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => European Society of Cardiology
[pdf] =>
[tjyjyw] =>
[lyyw] => If a patient in need of acute NCS also has chest pain or other symptoms suggestive of undetected CAD, a multidisciplinary assessment approach is recommended to choose the treatment with lowest total risk for the patient. (Evidence: Level C，Recommendation: Class Ⅰ)
[laiyuan] => 如果需要急诊NCS的患者同时有胸痛或其他提示未发现冠心病的症状，侧建议采用多学科评估方法来选择治疗，使患者的总风险最低。（证据级别：Level C ；推荐强度：Class Ⅰ）
[znzldj] => A
[_inputtime] => 1704957181
[_updatetime] => 1704957181
[_nrjc] =>
[_nrsh] =>
)
推荐意见
如果需要急诊NCS的患者同时有胸痛或其他提示未发现冠心病的症状，侧建议采用多学科评估方法来选择治疗，使患者的总风险最低。（证据级别：Level C ；推荐强度：Class Ⅰ）
If a patient in need of acute NCS also has chest pain or other symptoms suggestive of undetected CAD, a multidisciplinary assessment approach is recommended to choose the treatment with lowest total risk for the patient. (Evidence: Level C，Recommendation: Class Ⅰ)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：European Society of Cardiology
Array
(
[id] => 523
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/523.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:13:01
[updatetime] => 2024-01-11 15:13:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => European Society of Cardiology
[pdf] =>
[tjyjyw] =>
[lyyw] => In patients with symptomatic severe AR or asymptomatic severe AR and LVESD＞50 mm or LVESDi (LVESD/BSA)＞25 mm/m2 (in patients with small body size) or resting LVEF ≤50%, valve surgery is recommended prior to elective intermediate- or high-risk NCS.(Evidence: Level C，Recommendation: Class Ⅰ)
[laiyuan] => 对于有症状的重度主动脉瓣反流或无症状的重度主动脉瓣反流，且LVESD＞0.50 毫米或LVESDi (LVESD/BSA)＞0.25 mm/m2（对于体型较小的患者）或静息 LVEF≤50% 的患者，推荐在择期中危或高危NCS术之前进行瓣膜手术。（证据级别：Level C ；推荐强度：Class Ⅰ）
[znzldj] => A
[_inputtime] => 1704957181
[_updatetime] => 1704957181
[_nrjc] =>
[_nrsh] =>
)
推荐意见
对于有症状的重度主动脉瓣反流或无症状的重度主动脉瓣反流，且LVESD＞0.50 毫米或LVESDi (LVESD/BSA)＞0.25 mm/m2（对于体型较小的患者）或静息 LVEF≤50% 的患者，推荐在择期中危或高危NCS术之前进行瓣膜手术。（证据级别：Level C ；推荐强度：Class Ⅰ）
In patients with symptomatic severe AR or asymptomatic severe AR and LVESD＞50 mm or LVESDi (LVESD/BSA)＞25 mm/m2 (in patients with small body size) or resting LVEF ≤50%, valve surgery is recommended prior to elective intermediate- or high-risk NCS.(Evidence: Level C，Recommendation: Class Ⅰ)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：European Society of Cardiology
Array
(
[id] => 524
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/524.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:13:01
[updatetime] => 2024-01-11 15:13:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => European Society of Cardiology
[pdf] =>
[tjyjyw] =>
[lyyw] => In patients with suspected or known HF scheduled for high-risk NCS, it is recommended to evaluate LV function with echocardiography and measurement of NT-proBNP/BNP levels, unless this has recently been performed.(Evidence: Level B，Recommendation: Class Ⅰ)
[laiyuan] => 疑似或已知心衰患者择期行高风险NCS，推荐通过超声心动图评估左室功能及NT-proBNP/BNP 水平，除非最近已进行过此项检查。（证据级别：Level B ；推荐强度：Class Ⅰ）
[znzldj] => A
[_inputtime] => 1704957181
[_updatetime] => 1704957181
[_nrjc] =>
[_nrsh] =>
)
推荐意见
疑似或已知心衰患者择期行高风险NCS，推荐通过超声心动图评估左室功能及NT-proBNP/BNP 水平，除非最近已进行过此项检查。（证据级别：Level B ；推荐强度：Class Ⅰ）
In patients with suspected or known HF scheduled for high-risk NCS, it is recommended to evaluate LV function with echocardiography and measurement of NT-proBNP/BNP levels, unless this has recently been performed.(Evidence: Level B，Recommendation: Class Ⅰ)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：European Society of Cardiology
Array
(
[id] => 525
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/525.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:13:01
[updatetime] => 2024-01-11 15:13:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => European Society of Cardiology
[pdf] =>
[tjyjyw] =>
[lyyw] => It is recommended that patients with HF undergoing NCS receive optimal medical treatment according to current ESC Guidelines. (Evidence: Level A，Recommendation: Class Ⅰ)
[laiyuan] => 推荐接受NCS的心房颤动患者根据目前ESC指南进行优化治疗。（证据级别：Level A ；推荐强度：Class Ⅰ）
[znzldj] => A
[_inputtime] => 1704957181
[_updatetime] => 1704957181
[_nrjc] =>
[_nrsh] =>
)
推荐意见
推荐接受NCS的心房颤动患者根据目前ESC指南进行优化治疗。（证据级别：Level A ；推荐强度：Class Ⅰ）
It is recommended that patients with HF undergoing NCS receive optimal medical treatment according to current ESC Guidelines. (Evidence: Level A，Recommendation: Class Ⅰ)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：European Society of Cardiology
Array
(
[id] => 526
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/526.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:13:01
[updatetime] => 2024-01-11 15:13:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => European Society of Cardiology
[pdf] =>
[tjyjyw] =>
[lyyw] => In patients with a family history of genetic cardiomyopathy, it is recommended to perform an ECG and TTE before NCS, regardless of age and symptoms. (Evidence: Level C，Recommendation: Class Ⅰ)
[laiyuan] => 在有遗传性心肌病家族史的患者中，推荐在NCS术前行心电图和经胸超声心动图检查，不考虑年龄和症状。（证据级别：Level C ；推荐强度：Class Ⅰ）
[znzldj] => A
[_inputtime] => 1704957181
[_updatetime] => 1704957181
[_nrjc] =>
[_nrsh] =>
)
推荐意见
在有遗传性心肌病家族史的患者中，推荐在NCS术前行心电图和经胸超声心动图检查，不考虑年龄和症状。（证据级别：Level C ；推荐强度：Class Ⅰ）
In patients with a family history of genetic cardiomyopathy, it is recommended to perform an ECG and TTE before NCS, regardless of age and symptoms. (Evidence: Level C，Recommendation: Class Ⅰ)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：European Society of Cardiology
